Florida Senate - 2019                      CS for CS for SB 1180
       
       
        
       By the Committees on Health Policy; and Banking and Insurance;
       and Senators Mayfield and Harrell
       
       
       
       
       588-04046-19                                          20191180c2
    1                        A bill to be entitled                      
    2         An act relating to prescription drug formulary
    3         consumer protection; creating s. 627.42393, F.S.;
    4         requiring insurers issuing individual or group health
    5         insurance policies to provide certain notices to
    6         current and prospective insureds within a certain
    7         timeframe before the effective date of any change to a
    8         prescription drug formulary during a policy year;
    9         specifying requirements for a notice of medical
   10         necessity that an insured’s treating physician may
   11         submit to the insurer within a certain timeframe;
   12         specifying means by which the notice is to be
   13         submitted; requiring the Financial Services Commission
   14         to adopt a certain rule; specifying a requirement and
   15         prohibited acts relating to coverage changes by an
   16         insurer if the treating physician provides certain
   17         certification; providing construction and
   18         applicability; amending s. 627.6699, F.S.; requiring
   19         small employer carriers to comply with certain
   20         requirements for any change to a prescription drug
   21         formulary under the health benefit plan; amending s.
   22         641.31, F.S.; requiring health maintenance
   23         organizations to provide certain notices to current
   24         and prospective subscribers within a certain timeframe
   25         before the effective date of any change to a
   26         prescription drug formulary during a contract year;
   27         specifying requirements for a notice of medical
   28         necessity that a subscriber’s treating physician may
   29         submit to the health maintenance organization within a
   30         certain timeframe; specifying means by which the
   31         notice is to be submitted; requiring the commission to
   32         adopt a certain rule; specifying a requirement and
   33         prohibited acts relating to coverage changes by a
   34         health maintenance organization if the treating
   35         physician provides certain certification; providing
   36         construction and applicability; providing a
   37         declaration of important state interest; providing an
   38         effective date.
   39          
   40  Be It Enacted by the Legislature of the State of Florida:
   41  
   42         Section 1. Section 627.42393, Florida Statutes, is created
   43  to read:
   44         627.42393Health insurance policies; changes to
   45  prescription drug formularies; requirements.—
   46         (1)At least 60 days before the effective date of any
   47  change to a prescription drug formulary during a policy year, an
   48  insurer issuing individual or group health insurance policies in
   49  this state shall:
   50         (a)Provide general notification of the change in the
   51  formulary to current and prospective insureds in a readily
   52  accessible format on the insurer’s website; and
   53         (b)Notify, electronically or by first-class mail, any
   54  insured currently receiving coverage for a prescription drug for
   55  which the formulary change modifies coverage and the insured’s
   56  treating physician, including information on the specific drugs
   57  involved and a statement that the submission of a notice of
   58  medical necessity by the insured’s treating physician to the
   59  insurer at least 30 days before the effective date of the
   60  formulary change will result in continuation of coverage at the
   61  existing level.
   62         (2)The notice provided by the treating physician to the
   63  insurer must include a completed one-page form in which the
   64  treating physician certifies to the insurer that coverage of the
   65  prescription drug for the insured is medically necessary. The
   66  treating physician shall submit the notice electronically or by
   67  first-class mail. The insurer may provide the treating physician
   68  with access to an electronic portal through which the treating
   69  physician may electronically file the notice. The commission
   70  shall prescribe a form by rule for the notice.
   71         (3)If the treating physician certifies to the insurer, in
   72  accordance with subsection (2), that the prescription drug is
   73  medically necessary for the insured, the insurer:
   74         (a)Must authorize coverage for the prescribed drug based
   75  solely on the treating physician’s certification that coverage
   76  is medically necessary; and
   77         (b)May not modify the coverage related to the covered drug
   78  by:
   79         1.Increasing the out-of-pocket costs for the covered drug;
   80         2.Moving the covered drug to a more restrictive tier; or
   81         3.Denying an insured coverage of the drug for which the
   82  insured has been previously approved for coverage by the
   83  insurer.
   84         (4)This section does not:
   85         (a) Prohibit the addition of prescription drugs to the list
   86  of drugs covered under the policy during the policy year.
   87         (b)Apply to a grandfathered health plan as defined in s.
   88  627.402 or to benefits specified in s. 627.6513(1)-(14).
   89         (c)Alter or amend s. 465.025, which provides conditions
   90  under which a pharmacist may substitute a generically equivalent
   91  drug product for a brand name drug product.
   92         (d)Alter or amend s. 465.0252, which provides conditions
   93  under which a pharmacist may dispense a substitute biological
   94  product for the prescribed biological product.
   95         (e) Apply to a Medicaid managed care plan under part IV of
   96  chapter 409.
   97         Section 2. Paragraph (e) of subsection (5) of section
   98  627.6699, Florida Statutes, is amended to read:
   99         627.6699 Employee Health Care Access Act.—
  100         (5) AVAILABILITY OF COVERAGE.—
  101         (e) All health benefit plans issued under this section must
  102  comply with the following conditions:
  103         1. For employers who have fewer than two employees, a late
  104  enrollee may be excluded from coverage for no longer than 24
  105  months if he or she was not covered by creditable coverage
  106  continually to a date not more than 63 days before the effective
  107  date of his or her new coverage.
  108         2. Any requirement used by a small employer carrier in
  109  determining whether to provide coverage to a small employer
  110  group, including requirements for minimum participation of
  111  eligible employees and minimum employer contributions, must be
  112  applied uniformly among all small employer groups having the
  113  same number of eligible employees applying for coverage or
  114  receiving coverage from the small employer carrier, except that
  115  a small employer carrier that participates in, administers, or
  116  issues health benefits pursuant to s. 381.0406 which do not
  117  include a preexisting condition exclusion may require as a
  118  condition of offering such benefits that the employer has had no
  119  health insurance coverage for its employees for a period of at
  120  least 6 months. A small employer carrier may vary application of
  121  minimum participation requirements and minimum employer
  122  contribution requirements only by the size of the small employer
  123  group.
  124         3. In applying minimum participation requirements with
  125  respect to a small employer, a small employer carrier shall not
  126  consider as an eligible employee employees or dependents who
  127  have qualifying existing coverage in an employer-based group
  128  insurance plan or an ERISA qualified self-insurance plan in
  129  determining whether the applicable percentage of participation
  130  is met. However, a small employer carrier may count eligible
  131  employees and dependents who have coverage under another health
  132  plan that is sponsored by that employer.
  133         4. A small employer carrier shall not increase any
  134  requirement for minimum employee participation or any
  135  requirement for minimum employer contribution applicable to a
  136  small employer at any time after the small employer has been
  137  accepted for coverage, unless the employer size has changed, in
  138  which case the small employer carrier may apply the requirements
  139  that are applicable to the new group size.
  140         5. If a small employer carrier offers coverage to a small
  141  employer, it must offer coverage to all the small employer’s
  142  eligible employees and their dependents. A small employer
  143  carrier may not offer coverage limited to certain persons in a
  144  group or to part of a group, except with respect to late
  145  enrollees.
  146         6. A small employer carrier may not modify any health
  147  benefit plan issued to a small employer with respect to a small
  148  employer or any eligible employee or dependent through riders,
  149  endorsements, or otherwise to restrict or exclude coverage for
  150  certain diseases or medical conditions otherwise covered by the
  151  health benefit plan.
  152         7. An initial enrollment period of at least 30 days must be
  153  provided. An annual 30-day open enrollment period must be
  154  offered to each small employer’s eligible employees and their
  155  dependents. A small employer carrier must provide special
  156  enrollment periods as required by s. 627.65615.
  157         8. A small employer carrier shall comply with s. 627.42393
  158  for any change to a prescription drug formulary.
  159         Section 3. Subsection (36) of section 641.31, Florida
  160  Statutes, is amended to read:
  161         641.31 Health maintenance contracts.—
  162         (36) Except as provided in paragraphs (a), (b), and (c), a
  163  health maintenance organization may increase the copayment for
  164  any benefit, or delete, amend, or limit any of the benefits to
  165  which a subscriber is entitled under the group contract only,
  166  upon written notice to the contract holder at least 45 days in
  167  advance of the time of coverage renewal. The health maintenance
  168  organization may amend the contract with the contract holder,
  169  with such amendment to be effective immediately at the time of
  170  coverage renewal. The written notice to the contract holder must
  171  shall specifically identify any deletions, amendments, or
  172  limitations to any of the benefits provided in the group
  173  contract during the current contract period which will be
  174  included in the group contract upon renewal. This subsection
  175  does not apply to any increases in benefits. The 45-day notice
  176  requirement does shall not apply if benefits are amended,
  177  deleted, or limited at the request of the contract holder.
  178         (a) At least 60 days before the effective date of any
  179  change to a prescription drug formulary during a contract year,
  180  the health maintenance organization shall:
  181         1.Provide general notification of the change in the
  182  formulary to current and prospective subscribers in a readily
  183  accessible format on the health maintenance organization’s
  184  website; and
  185         2.Notify, electronically or by first-class mail, any
  186  subscriber currently receiving coverage for a prescription drug
  187  for which the formulary change modifies coverage and the
  188  subscriber’s treating physician, including information on the
  189  specific drugs involved and a statement that the submission of a
  190  notice of medical necessity by the subscriber’s treating
  191  physician to the health maintenance organization at least 30
  192  days before the effective date of the formulary change will
  193  result in continuation of coverage at the existing level.
  194         (b)The notice provided by the treating physician to the
  195  insurer must include a completed one-page form in which the
  196  treating physician certifies to the health maintenance
  197  organization that coverage of the prescription drug for the
  198  subscriber is medically necessary. The treating physician shall
  199  submit the notice electronically or by first-class mail. The
  200  health maintenance organization may provide the treating
  201  physician with access to an electronic portal through which the
  202  treating physician may electronically file the notice. The
  203  commission shall prescribe a form by rule for the notice.
  204         (c)If the treating physician certifies to the health
  205  maintenance organization, in accordance with paragraph (b), that
  206  the prescription drug is medically necessary for the subscriber,
  207  the health maintenance organization:
  208         1.Must authorize coverage for the prescribed drug based
  209  solely on the treating physician’s certification that coverage
  210  is medically necessary; and
  211         2.May not modify the coverage related to the covered drug
  212  by:
  213         a.Increasing the out-of-pocket costs for the covered drug;
  214         b.Moving the covered drug to a more restrictive tier; or
  215         c.Denying a subscriber coverage of the drug for which the
  216  subscriber has been previously approved for coverage by the
  217  health maintenance organization.
  218         (d) Paragraphs (a), (b), and (c) do not:
  219         1. Prohibit the addition of prescription drugs to the list
  220  of drugs covered under the contract during the contract year.
  221         2. Apply to a grandfathered health plan as defined in s.
  222  627.402 or to benefits specified in s. 627.6513(1)-(14).
  223         3. Alter or amend s. 465.025, which provides conditions
  224  under which a pharmacist may substitute a generically equivalent
  225  drug product for a brand name drug product.
  226         4. Alter or amend s. 465.0252, which provides conditions
  227  under which a pharmacist may dispense a substitute biological
  228  product for the prescribed biological product.
  229         5. Apply to a Medicaid managed care plan under part IV of
  230  chapter 409.
  231         Section 4. The Legislature finds that this act fulfills an
  232  important state interest.
  233         Section 5. This act shall take effect January 1, 2020.